Celltrion Healthcare IPO Part 3 - What Local Institutions Seem to Have in Mind
Celltrion Healthcare (091990 KS) officials are currently meeting Korea's local institutional investors for its IPO. Local roadshow began on June...
291 Views
Samsung Electronics May Reverse Treasury Share Cancellation Decision
I think it is really time to talk more candidly about Samsung's restructuring problems. In the last 4 weeks (since May 8 to last Friday). C&T...
261 Views
Summary of KOSPI200 & KOSDAQ150 Upcoming Reshuffle
As I said in my earlier comment, Samsung Biologics Co., Ltd (207940 KS) seems to be benefiting a lot from its inclusion in KOSPI200 index. Perhaps...
2.2k Views
WuXi Biologics IPO Review - An Opportunity to Get Exposure to Biologics in China
WuXi Biologics (2269 HK) is looking to raise US$461-511m through the issuance of primary (88%) and secondary (12%) shares. Proceeds will be used...
784 Views
WuXi Biologics: Pass on This Valuation
The company's underwriters have announced a price range of HK$18.60 - HK$20.60 which implies a market cap of US$2.7-3.0 billion. We recommend...
758 Views